A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers
NCT05360680
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Colorectal Cancer
Gastric Cancer
Pancreatic Cancer
Ovarian Cancer
Interventions
DRUG:
CUE-102
Sponsor
Cue Biopharma